1. Hematological adverse events in the management of glioblastoma
    Catherine R. Garcia et al, 2022, Journal of Neuro-Oncology CrossRef
  2. Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results fromĀ AINO study (Italian Association for Neuro-Oncology)
    Veronica Villani et al, 2021, Journal of Neurology CrossRef